Dearborn Partners LLC acquired a new position in Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 28,921 shares of the company’s stock, valued at approximately $3,716,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MKGAF. Frazier Financial Advisors LLC purchased a new stake in Merck KGaA during the second quarter valued at about $25,000. Rakuten Securities Inc. bought a new position in Merck KGaA during the second quarter worth about $27,000. Solstein Capital LLC purchased a new position in shares of Merck KGaA in the second quarter worth about $33,000. Delos Wealth Advisors LLC purchased a new position in shares of Merck KGaA in the second quarter worth about $33,000. Finally, Burk Holdings LLC bought a new stake in shares of Merck KGaA in the second quarter valued at approximately $39,000. 0.10% of the stock is currently owned by institutional investors.
Merck KGaA Stock Performance
Shares of MKGAF stock opened at $158.15 on Friday. The firm’s 50 day moving average is $163.21 and its 200 day moving average is $148.95. The stock has a market capitalization of $20.44 billion, a P/E ratio of 24.14 and a beta of 0.96. Merck KGaA has a 12 month low of $116.68 and a 12 month high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- Nutanix’s Rally Has a Bigger Story Than Earnings as AMD’s AI Bet Takes Shape
- SEC Probe Puts Wall Street Leverage Risk Back in Focus
- A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole
- Five Below’s Turnaround Is Working—But Has the Stock Run Too Far?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
